Cargando…

The human intermediate prolactin receptor is a mammary proto-oncogene

The hormone prolactin (PRL) and its receptor (hPRLr) are significantly involved in breast cancer pathogenesis. The intermediate hPRLr (hPRLrI) is an alternatively-spliced isoform, capable of stimulating cellular viability and proliferation. An analogous truncated mouse PRLr (mPRLr) was recently foun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grible, Jacqueline M., Zot, Patricija, Olex, Amy L., Hedrick, Shannon E., Harrell, J. Chuck, Woock, Alicia E., Idowu, Michael O., Clevenger, Charles V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997966/ https://www.ncbi.nlm.nih.gov/pubmed/33772010 http://dx.doi.org/10.1038/s41523-021-00243-7

Ejemplares similares

SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene
por: Grible, Jacqueline M, et al.
Publicado: (2020)

Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer
por: Woock, Alicia E., et al.
Publicado: (2021)

SAT-139 STAT5A Regulation by Serine Phosphorylation in Breast Cancer
por: Woock, Alicia E, et al.
Publicado: (2020)

Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer
por: Rashid, Narmeen S., et al.
Publicado: (2021)

Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer
por: Byers, Holly A., et al.
Publicado: (2023)

Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases
por: Hakim, Shawn, et al.
Publicado: (2020)

Role of proto-oncogene activation in carcinogenesis.
por: Anderson, M W, et al.
Publicado: (1992)

The Biology of the Ets1 Proto-Oncogene
por: Dittmer, Jürgen
Publicado: (2003)

Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2021)

Expression of ret Proto‐oncogene in Human Neuroblastomas
por: Nagao, Minako, et al.
Publicado: (1990)

Roles of the RET Proto-oncogene in Cancer and Development
por: Takahashi, Masahide, et al.
Publicado: (2020)

PBF, a Proto-oncogene in Esophageal Carcinoma
por: Lian, Shi-hai, et al.
Publicado: (2019)

Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
por: Ordás, Javier, et al.
Publicado: (2007)

A high-fat diet increases the incidence of mammary cancer inc-Ha-ras proto-oncogene transgenic rats
por: Magaki, Mie, et al.
Publicado: (2016)

Activation of proto-oncogenes in human and mouse lung tumors.
por: Reynolds, S H, et al.
Publicado: (1991)

Analyses of domains and domain fusions in human proto-oncogenes
por: Liu, Qi, et al.
Publicado: (2009)

The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs
por: Nairismägi, Maarja-Liisa, et al.
Publicado: (2013)

The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016)

Distribution of RET proto‐oncogene variants in children with appendicitis
por: Schultz, Jurek, et al.
Publicado: (2022)

Laser nanostructured gold biosensor for proto-oncogene detection
por: Hughes, Cian, et al.
Publicado: (2023)

Multiple Myeloma Presenting as a Fistulous Rectal Mass Eroding Into the Retroperitoneum
por: Syed, Taseen, et al.
Publicado: (2021)

Colon Adenocarcinoma Metastasis Through Ileocolic Fistula to Small Bowel in the Setting of Crohn's Disease
por: Tseng, Michael T., et al.
Publicado: (2022)

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
por: Hathaway, Cassandra A., et al.
Publicado: (2023)

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas
por: Michel, Erika, et al.
Publicado: (2012)

Discovering Synergistic Compounds with BYL-719 in PI3K Overactivated Basal-like PDXs
por: Boyd, David C., et al.
Publicado: (2023)

Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer
por: Zboril, Emily K., et al.
Publicado: (2023)

Mammary Carcinomas Induced in Human c‐Ha‐ras Proto‐oncogene Transgenic Rats Are Estrogen‐independent, but Responsive to d‐Limonene Treatment
por: Asamoto, Makoto, et al.
Publicado: (2002)

Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
por: Smith, D. R., et al.
Publicado: (1993)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

The expression and significance of proto-oncogene c-fos in viral myocarditis
por: Zhang, Song, et al.
Publicado: (2010)

The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

Characterization of the Promoter Region of the Human c‐kit Proto‐oncogene
por: Yamamoto, Katsuya, et al.
Publicado: (1993)

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
por: Geng, Xiangrong, et al.
Publicado: (2022)

RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy
por: Kucharczyk, Tomasz, et al.
Publicado: (2022)

Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin
por: Watkins, Rachel J., et al.
Publicado: (2016)

Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer
por: Rashid, Narmeen S., et al.
Publicado: (2022)

Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat.
por: Welsch, C. W., et al.
Publicado: (1975)

G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription
por: Cogoi, Susanna, et al.
Publicado: (2006)

Bioinformatics of non small cell lung cancer and the ras proto-oncogene
por: Kashyap, Amita, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hb4dh5q4r4npu3cnpqaobvdnkj